Cytokinetics (CYTK) Revenue (2016 - 2024)
Historic Revenue for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to -$8.9 million.
- Cytokinetics' Revenue fell 63456.94% to -$8.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.4 million, marking a year-over-year decrease of 19815.41%. This contributed to the annual value of -$37.7 million for FY2024, which is 60067.73% down from last year.
- Cytokinetics' Revenue amounted to -$8.9 million in Q4 2024, which was down 63456.94% from $463000.0 recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Revenue registered a high of $89.0 million during Q2 2022, and its lowest value of -$12.6 million during Q4 2020.
- Moreover, its 5-year median value for Revenue was $2.2 million (2022), whereas its average is $9.3 million.
- Its Revenue has fluctuated over the past 5 years, first soared by 302937.04% in 2022, then tumbled by 63456.94% in 2024.
- Over the past 5 years, Cytokinetics' Revenue (Quarter) stood at -$12.6 million in 2020, then skyrocketed by 417.88% to $40.1 million in 2021, then plummeted by 95.12% to $2.0 million in 2022, then fell by 14.56% to $1.7 million in 2023, then plummeted by 634.57% to -$8.9 million in 2024.
- Its Revenue stands at -$8.9 million for Q4 2024, versus $463000.0 for Q3 2024 and $249000.0 for Q2 2024.